KEVORK VORPERIAN: Open Payments
NPI 1568468650 · SUNLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 15 payments from 8 companies in 2025. Trend: 2023 $489 · 2024 $268 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 4 | $194 |
| ABBVIE INC. | 3 | $87 |
| Regeneron Healthcare Solutions, Inc. | 2 | $67 |
| PFIZER INC. | 2 | $67 |
| GlaxoSmithKline, LLC. | 1 | $35 |
| Lilly USA, LLC | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: ZORYVE, DUPIXENT, ELIQUIS, LINZESS, TRELEGY ELLIPTA, MOUNJARO, Kerendia, CREON.
Industry payments across CA — which companies pay providers there.
